Science Corporation has implanted its vision-restoring chip in its first patient with Stargardt disease, a rare genetic eye disorder. The company, led by Max Hodak, former president and co-founder of Neuralink, detailed the milestone on stage at TechCrunch Disrupt, saying its work with PRIMA is part